Kashanchi F - Search Results

1

Effect of mimetic CDK9 inhibitors on HIV-1-activated transcription.

Van Duyne R, Guendel I, Jaworski E, Sampey G, Klase Z, Chen H, Zeng C, Kovalskyy D, El Kouni MH, Lepene B, Patanarut A, Nekhai S, Price DH, Kashanchi F. Van Duyne R, et al. Among authors: kashanchi f. J Mol Biol. 2013 Feb 22;425(4):812-29. doi: 10.1016/j.jmb.2012.12.005. Epub 2012 Dec 13. J Mol Biol. 2013. PMID: 23247501 Free PMC article.

2

Tat modifies the activity of CDK9 to phosphorylate serine 5 of the RNA polymerase II carboxyl-terminal domain during human immunodeficiency virus type 1 transcription.

Zhou M, Halanski MA, Radonovich MF, Kashanchi F, Peng J, Price DH, Brady JN. Zhou M, et al. Among authors: kashanchi f. Mol Cell Biol. 2000 Jul;20(14):5077-86. doi: 10.1128/MCB.20.14.5077-5086.2000. Mol Cell Biol. 2000. PMID: 10866664 Free PMC article.

3

Inhibition of human immunodeficiency virus type 1 transcription by chemical cyclin-dependent kinase inhibitors.

Wang D, de la Fuente C, Deng L, Wang L, Zilberman I, Eadie C, Healey M, Stein D, Denny T, Harrison LE, Meijer L, Kashanchi F. Wang D, et al. Among authors: kashanchi f. J Virol. 2001 Aug;75(16):7266-79. doi: 10.1128/JVI.75.16.7266-7279.2001. J Virol. 2001. PMID: 11461999 Free PMC article.

4

HIV-1 Tat interaction with RNA polymerase II C-terminal domain (CTD) and a dynamic association with CDK2 induce CTD phosphorylation and transcription from HIV-1 promoter.

Deng L, Ammosova T, Pumfery A, Kashanchi F, Nekhai S. Deng L, et al. Among authors: kashanchi f. J Biol Chem. 2002 Sep 13;277(37):33922-9. doi: 10.1074/jbc.M111349200. Epub 2002 Jul 11. J Biol Chem. 2002. PMID: 12114499 Free article.

5

Inhibition of HTLV-1 transcription by cyclin dependent kinase inhibitors.

Wang L, Deng L, Wu K, de la Fuente C, Wang D, Kehn K, Maddukuri A, Baylor S, Santiago F, Agbottah E, Trigon S, Morange M, Mahieux R, Kashanchi F. Wang L, et al. Among authors: kashanchi f. Mol Cell Biochem. 2002 Aug;237(1-2):137-53. doi: 10.1023/a:1016555821581. Mol Cell Biochem. 2002. PMID: 12236581

6

Pharmacological cyclin-dependent kinase inhibitors as HIV-1 antiviral therapeutics.

de la Fuente C, Maddukuri A, Kehn K, Baylor SY, Deng L, Pumfery A, Kashanchi F. de la Fuente C, et al. Among authors: kashanchi f. Curr HIV Res. 2003 Apr;1(2):131-52. doi: 10.2174/1570162033485339. Curr HIV Res. 2003. PMID: 15043199 Review.

7

Chromatin remodeling and modification during HIV-1 Tat-activated transcription.

Pumfery A, Deng L, Maddukuri A, de la Fuente C, Li H, Wade JD, Lambert P, Kumar A, Kashanchi F. Pumfery A, et al. Among authors: kashanchi f. Curr HIV Res. 2003 Jul;1(3):343-62. doi: 10.2174/1570162033485186. Curr HIV Res. 2003. PMID: 15046258 Review.

8

RNA interference directed to CDK2 inhibits HIV-1 transcription.

Ammosova T, Berro R, Kashanchi F, Nekhai S. Ammosova T, et al. Among authors: kashanchi f. Virology. 2005 Oct 25;341(2):171-8. doi: 10.1016/j.virol.2005.06.041. Epub 2005 Aug 8. Virology. 2005. PMID: 16085226 Free article.

9

Nuclear targeting of protein phosphatase-1 by HIV-1 Tat protein.

Ammosova T, Jerebtsova M, Beullens M, Lesage B, Jackson A, Kashanchi F, Southerland W, Gordeuk VR, Bollen M, Nekhai S. Ammosova T, et al. Among authors: kashanchi f. J Biol Chem. 2005 Oct 28;280(43):36364-71. doi: 10.1074/jbc.M503673200. Epub 2005 Aug 29. J Biol Chem. 2005. PMID: 16131488 Free article.

10

Inhibition of HIV-1 virus replication using small soluble Tat peptides.

Agbottah E, Zhang N, Dadgar S, Pumfery A, Wade JD, Zeng C, Kashanchi F. Agbottah E, et al. Among authors: kashanchi f. Virology. 2006 Feb 20;345(2):373-89. doi: 10.1016/j.virol.2005.09.062. Epub 2005 Nov 14. Virology. 2006. PMID: 16289656 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page